The "Kardashian Effect"--it's a term to describe the way reality TV's Kardashian family, especially daughter Kim, influences beauty and fashion trends. Now, the Kardashian Effect has come to pharma.
Stereotyping in male-dominated professions like engineering is nothing new. But one young female engineer in San Francisco had enough, after she appeared in an ad for her company--and then faced a backlash on social media. She didn't look like an engineer, the critics said.
Brands are ditching agencies and bringing digital marketing in-house in bigger numbers than ever, and that includes pharma companies. A new study from the Society of Digital Agencies found that "the percentage of clients taking full responsibility for digital efforts at their companies grew significantly" year over year.
Social media success in consumer marketing has advanced beyond counting fans and followers. Today it's all about shares, retweets and links that indicate real consumer engagement with brands....
A congressman is taking aim at perceived flaws in FDA's long-awaited, much-discussed guidance on the use of Twitter.
A Missouri congressman wants to know why the pharma industry is sitting on the sidelines of social media. Actually, Rep. Billy Long (R-MO) has an idea why--and he's proposing legislation to change it. He recently introduced H.R. 2479, which would force the FDA to let pharma share more info about its products online.
In a recent study divining social insights for pharma, several companies noted they had never thought of using social media that way. The other significant feedback centered on regulations, particularly adverse events and the question of whether findings via social listening would have to be reported.
HBO premiered an award-winning short documentary about Huntington's disease, a rare, hereditary neurological malady, on Monday night. The film follows actress and filmmaker Marianne Palka as she finds out the results of her genetic test. If someone has a parent with the disease as she did, they have a 50/50 chance of getting the disease. The missing voice? Pharma.
Large pharma companies are posting 530% more tweets a week than in 2013, a study by Ogilvy Healthworld found. The healthcare communications group tracked the social media activity of 14 large pharma companies for one week per month over three months.
Bigger isn't necessarily better when it comes to social media. But bigger is certainly better than drugmakers were doing a couple of years ago. Some companies are actually getting it right now, Ogilvy Healthworld says.